Biokin Pharma secures first China approval for Iza-bren in Nasopharyngeal carcinoma

U.S. FDA approves Trodelvy for first-line treatment of metastatic TNBC

European Commission approves Trodelvy for first-line metastatic TNBC

European Commission approves PADCEV as perioperative treatment for cisplatin-ineligible patients with resectable MIBC

NMPA accepts Tecotabart Vedotin NDA for third-line CLDN18.2+ Gastric cancer

Lonza and InduPro announce licensing agreement to advance next-generation ADC therapeutics